Advertisement

BCNP Consultants European Chemistry Partnering 2017 Ffm Germany 600x60px
Document › Details

Varian, Inc.. (2/8/10). "Press Release: Varian, Inc. Files Form 10-Q for First Quarter 2010".

Organisation Organisation Varian Inc. (Group)
  Today Varian Inc. (Nasdaq: VARI)
Product Product analytical instrument
     


Varian, Inc. (NasdaqGS: VARI) today reported that it has filed with the U.S. Securities and Exchange Commission its Quarterly Report on Form 10-Q for the first quarter of its fiscal year 2010. That Form 10-Q provides financial and related information on the Company's first fiscal quarter, which ended January 1, 2010.

For a complete reconciliation of certain non-GAAP (adjusted) financial information for the first quarter of fiscal years 2009 and 2010 to the most directly comparable GAAP financial information, please refer to the attached Reconciliations of GAAP to Adjusted Results-Actual.

Non-GAAP (Adjusted) Financial Measures

This press release includes non-GAAP (adjusted) financial measures for cost of sales, selling, general and administrative expenses, research and development expenses, operating earnings, operating profit margins, income tax expense, net earnings and diluted earnings per share. These non-GAAP financial measures exclude acquisition-related intangible and inventory write-up amortization, costs related to the pending acquisition of the Company by Agilent Technologies, Inc. ("Agilent") and restructuring and other related costs. Reconciliations of each of these non-GAAP financial measures to the most directly comparable GAAP financial measures are detailed in the Reconciliations of GAAP to Adjusted Results attached to this press release. We believe that presentation of these non-GAAP financial measures provides useful information to investors regarding our results of operations and our cash flows.

We believe that excluding acquisition-related intangible and inventory write-up amortization provides supplemental information and an alternative presentation useful to investors' understanding of the company's core operating results and trends. In addition, investors have indicated to us that they analyze the benefits of acquisitions based on the cash return on the investment made, and thus consider financial measures excluding acquisition-related intangible and inventory write-up amortization as important, useful information.

We similarly believe that excluding costs related to the pending acquisition by Agilent and restructuring and other related costs (principally related to facility closures and employee terminations to reduce costs and improve operational efficiency) provides supplemental information and an alternative presentation useful to investors' understanding of the company's core operating results and trends, especially when comparing those results on a consistent basis to results for previous periods and anticipated results for future periods. Investors have indicated that they consider financial measures of our results of operations excluding restructuring and other related costs as important supplemental information useful to their understanding of our historical results and estimating of our future results.

We also believe that, in excluding acquisition-related intangible and inventory write-up amortization, costs related to the pending acquisition by Agilent and restructuring and other related costs, our non-GAAP financial measures provide investors with transparency into what is used by management to measure and forecast our results of operations, to compare on a consistent basis our results of operations for the current period to that of prior periods, to compare our results of operations on a more consistent basis against that of other companies, in making financial and operating decisions and to establish certain management compensation.

We believe that our non-GAAP financial measures should only be considered in addition to, and not as a substitute for or superior to, our financial measures prepared in accordance with GAAP.

About Varian, Inc.

Varian, Inc. is a leading worldwide supplier of scientific instruments and vacuum technologies for life science, environmental, energy, and applied research and other applications. The company provides complete solutions, including instruments, vacuum products, laboratory consumable supplies, software, training and support through its global distribution and support systems. Varian, Inc.'s common stock is traded on the NASDAQ Global Select Market under the symbol "VARI". Further information is available on the company's Web site at http://www.varianinc.com.

For Information Contact:

Investor Relations
Varian, Inc.
650.424.5471
ir@varianinc.com

VARIAN, INC. AND SUBSIDIARY COMPANIES
RECONCILIATION OF GAAP TO ADJUSTED RESULTS - ACTUAL
UNAUDITED RESULTS OF OPERATIONS
(In thousands, except margin data)

First Quarter FY 2010 and First Quarter FY 2009

Fiscal Quarter Ended
------------------------
January 1, January 2,
2010 2009
---------- ----------
TOTAL COMPANY
-------------
Cost of Sales
U.S. GAAP as reported $114,303 $112,915
Adjustments:
Acquisition-related intangible amortization (1,602) (1,603)
Acquisition-related inventory write-up
amortization (30) (17)
Restructuring and other related costs (205) (935)
---------- ----------
As adjusted $112,466 $110,360
========== ==========

Selling, General and Administrative
U.S. GAAP as reported $ 59,877 $ 60,916
Adjustments:
Acquisition-related intangible amortization (194) (452)
Costs related to pending acquisition by
Agilent (3,191) -
Restructuring and other related costs (131) (559)
---------- ----------
As adjusted $ 56,361 $ 59,905
========== ==========

Research and Development
U.S. GAAP as reported $ 14,546 $ 14,514
Adjustments:
Restructuring and other related costs (408) (218)
---------- ----------
As adjusted $ 14,138 $ 14,296
========== ==========

Operating Earnings
U.S. GAAP as reported $ 12,454 $ 19,891
Adjustments:
Acquisition-related intangible amortization 1,796 2,055
Acquisition-related inventory write-up
amortization 30 17
Costs related to pending acquisition by
Agilent 3,191 -
Restructuring and other related costs 744 1,712
---------- ----------
As adjusted $ 18,215 $ 23,675
========== ==========

Operating Margins
U.S. GAAP as reported 6.2% 9.6%
Adjustments:
Acquisition-related intangible amortization 0.9 1.0
Acquisition-related inventory write-up
amortization 0.0 0.0
Costs related to pending acquisition by
Agilent 1.6 -
Restructuring and other related costs 0.4 0.8
---------- ----------
As adjusted 9.1% 11.4%
========== ==========



VARIAN, INC. AND SUBSIDIARY COMPANIES
RECONCILIATION OF GAAP TO ADJUSTED RESULTS - ACTUAL
UNAUDITED RESULTS OF OPERATIONS
(In thousands, except per share amounts)

First Quarter FY 2010 and First Quarter FY 2009


Fiscal Quarter Ended
------------------------
January 1, January 2,
2010 2009
---------- ----------
TOTAL COMPANY (Continued)
-------------------------
Income Tax Expense
U.S. GAAP as reported $ 4,580 $ 7,115
Tax impact of adjustments:
Acquisition-related intangible amortization 652 675
Acquisition-related inventory write-up
amortization 9 5
Costs related to pending acquisition by
Agilent 864 -
Restructuring and other related costs 321 584
---------- ----------
As adjusted $ 6,426 $ 8,379
========== ==========

Net Earnings
U.S. GAAP as reported $ 8,071 $13,041
Adjustments:
Acquisition-related intangible amortization 1,144 1,380
Acquisition-related inventory write-up
amortization 21 12
Costs related to pending acquisition by
Agilent 2,327 -
Restructuring and other related costs 423 1,128
---------- ----------
As adjusted $11,986 $15,561
========== ==========

Diluted Earnings Per Share
U.S. GAAP as reported $ 0.28 $ 0.45
Adjustments:
Acquisition-related intangible amortization 0.04 0.05
Acquisition-related inventory write-up
amortization 0.00 0.00
Costs related to pending acquisition by
Agilent 0.08 -
Restructuring and other related costs 0.01 0.04
---------- ----------
As adjusted $ 0.41 $ 0.54
========== ==========




VARIAN, INC. AND SUBSIDIARY COMPANIES
RECONCILIATION OF GAAP TO ADJUSTED RESULTS - ACTUAL
UNAUDITED RESULTS OF OPERATIONS
(In thousands, except margin data)

First Quarter FY 2010 and First Quarter FY 2009

Fiscal Quarter Ended
------------------------
January 1, January 2,
2010 2009
---------- ----------
SCIENTIFIC INSTRUMENTS SEGMENT
------------------------------
Operating Earnings
U.S. GAAP as reported $ 9,422 $16,423
Adjustments:
Acquisition-related intangible amortization 1,796 2,055
Acquisition-related inventory write-up
amortization 30 17
Costs related to pending acquisition by
Agilent 1,815 -
Restructuring and other related costs 726 1,591
---------- ----------
As adjusted $13,789 $20,086
========== ==========
Operating Margins
U.S. GAAP as reported 5.7% 9.6%
Adjustments:
Acquisition-related intangible amortization 1.1 1.2
Acquisition-related inventory write-up
amortization 0.0 0.0
Costs related to pending acquisition by
Agilent 1.1 -
Restructuring and other related costs 0.4 0.9
---------- ----------
As adjusted 8.3% 11.7%
========== ==========

VACUUM TECHNOLOGIES SEGMENT
---------------------------
Operating Earnings
U.S. GAAP as reported $ 7,117 $ 7,036
Adjustments:
Restructuring and other related costs 18 121
---------- ----------
As adjusted $ 7,135 $ 7,157
========== ==========

Operating Margins
U.S. GAAP as reported 20.6% 19.3%
Adjustments:
Restructuring and other related costs 0.0 0.3
---------- ----------
As adjusted 20.6% 19.6%
========== ==========

GENERAL (UNALLOCATED) CORPORATE
-------------------------------
Operating Earnings
U.S. GAAP as reported $(4,085) $(3,568)
Adjustments:
Costs related to pending acquisition by
Agilent 1,376 -
---------- ----------
As adjusted $(2,709) $(3,568)
========== ==========

   
Record changed: 2016-03-19

Advertisement

BCNP Consultants European Chemistry Partnering 2017 Ffm Germany 600x60px

More documents for Agilent (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture AB Sciex Berliner LCMSMS Symposium 2017 Middle 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px BCNP Consultants European Chemistry Partnering 2017 Ffm Germany 120x180px Picture EBD Group BIO-Europe Spring 2017 BES Barcelona Spain March 120x180px Picture AB Sciex Berliner LCMSMS Symposium 2017 Right 120x80px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px